Related content

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations

By Bayraktar Soley  

Breast Cancer Research and Treatment, Vol. 130, Iss. 1, 2011-11 ,pp. : 145-153

Springer Publishing Company

Access to resources Recommend Favorite

Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi Women

By Comen E.   Davids M.   Kirchhoff T.   Hudis C.   Offit K.   Robson M.  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 185-190

Springer Publishing Company

Access to resources Recommend Favorite

Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women

By Kabat Geoffrey  

Cancer Causes and Control, Vol. 22, Iss. 5, 2011-05 ,pp. : 775-783

Springer Publishing Company

Access to resources Recommend Favorite

Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age

By Li Christopher  

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 579-587

Springer Publishing Company

Access to resources Recommend Favorite

Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence

By Juan Jiménez Inmaculada   García Casado Zaida   Palanca Suela Sarai   Esteban Cardeñosa Eva   López Guerrero José   Segura Huerta Ángel   Chirivella González Isabel   Sánchez Heras Ana   Juan Fita Mª   Tena García Isabel   Guillen Ponce Carmen   Martínez de Dueñas Eduardo   Romero Noguera Ignacio   Salas Trejo Dolores   Goicoechea Sáez Mercedes   Bolufer Gilabert Pascual  

Familial Cancer, Vol. 12, Iss. 4, 2013-12 ,pp. : 767-777

Springer Publishing Company

Access to resources Recommend Favorite